면역력 강화 제품 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 유통 채널별, 지역별＆경쟁(2021-2031년)

The Global Immunity Boosting Products Market is projected to expand from USD 31.16 Billion in 2025 to USD 48.14 Billion by 2031, progressing at a CAGR of 7.52%. These products encompass dietary supplements, functional foods, and beverages fortified with active ingredients like vitamins, minerals, probiotics, and botanicals designed to strengthen the human immune system. Market growth is primarily driven by a structural transition in consumer behavior toward preventive healthcare, where individuals prioritize long-term wellness and disease avoidance over reactive medical treatments. This sustained demand is further supported by an aging global population and increased awareness of nutritional deficiencies, ensuring the category remains relevant throughout the year. For instance, the Council for Responsible Nutrition reported in 2024 that 30 percent of dietary supplement users identified immune health as a leading motivation for their regimen, highlighting the sector's enduring vitality.

Despite these positive growth trajectories, the Global Immunity Boosting Products Market encounters a substantial challenge due to regulatory fragmentation across various international jurisdictions. Inconsistent standards regarding permissible health claims, ingredient safety thresholds, and labeling requirements establish complex barriers for manufacturers seeking to scale operations globally. This regulatory disparity frequently compels companies to customize formulations for specific markets, leading to escalated production costs and supply chain inefficiencies that can hinder rapid market expansion.

Market Driver

A primary catalyst for the Global Immunity Boosting Products Market is the increasing consumer emphasis on preventive healthcare and wellness, which is fundamentally shifting purchasing habits from seasonal reactivity to proactive daily management. As individuals become more aware of the connection between immune resilience and overall longevity, they are incorporating immunity-supporting products into their everyday routines. This trend is substantiated by recent consumer sentiment; according to the 'Immune Health in 2024 and Beyond' report by Kyowa Hakko in September 2024, 51 percent of consumers expressed greater concern about their immune health compared to two years prior. This elevated anxiety and prioritization drive consistent demand for supplements and functional products that provide continuous defense rather than temporary relief.

Furthermore, the market is propelled by surging demand for natural, organic, and plant-based ingredients, as consumers increasingly examine labels for clean, scientifically validated components. This preference is generating significant economic activity within the supply chain for key immune-modulating raw materials. As noted in the '2024 Global EPA and DHA Omega-3 Ingredient Market Report' by the Global Organization for EPA and DHA Omega-3s in September 2024, the value of the global omega-3 ingredient market rose by 22.5 percent in 2023, reflecting rising costs and premiumization. Additionally, the International Probiotics Association projected in 2024 that probiotic supplement sales in the Asia Pacific region would maintain a 9.2 percent growth rate through 2028, underscoring strong regional momentum for natural immune solutions.

Market Challenge

Regulatory fragmentation across international jurisdictions remains a significant barrier restricting the growth of the Global Immunity Boosting Products Market. Manufacturers facing divergent standards regarding permissible health claims and ingredient safety limits are unable to effectively leverage economies of scale. This situation forces companies to develop multiple variations of the same product to comply with conflicting local laws, inevitably increasing production costs and complicating supply chain logistics. Consequently, financial resources that could be invested in research and market development are instead consumed by the substantial costs associated with compliance, relabeling, and reformulation.

The impact of this disjointed regulatory environment hampers the speed at which companies can enter new territories and creates operational friction. This complexity is intensified when fragmentation occurs even within single key markets, adding further layers of difficulty to an already intricate landscape. For example, the Natural Products Association reported in 2024 that 13 states demonstrated a willingness to consider creating state-level regulatory schemes, threatening to replace unified federal frameworks with a patchwork of local mandates. Such regulatory volatility compels businesses to adopt a cautious, piecemeal approach to expansion rather than executing aggressive global strategies.

Market Trends

The convergence of immunity with stress and sleep support is rapidly advancing as consumers increasingly acknowledge the psychobiological connection between mental well-being and immune resilience. Rather than addressing these health aspects in isolation, individuals are seeking holistic formulations that simultaneously manage anxiety, sleep deprivation, and immune defense, thereby optimizing their wellness regimens. This demand for multi-functional solutions is supported by data on shifting health priorities; according to the 'Health expectancy: Latest global consumer insights' article by DSM-Firmenich in December 2024, mental and emotional health (48 percent) and immunity (44 percent) were identified as top concurrent health concerns, driving the development of hybrid products combining immune-modulators with adaptogens and relaxants.

Simultaneously, the market is seeing a decisive integration of immune benefits into functional foods and beverages, shifting the category away from traditional pharmaceutical-like formats. Manufacturers are addressing "pill fatigue" by fortifying everyday consumables-such as snacks, yogurts, and juices-with immune-supporting ingredients, making health management a seamless part of daily nutrition rather than a medical task. This expansion into lifestyle-oriented formats is strongly supported by consumer interest; according to the 'Immune Health in 2024 and Beyond' report by Kyowa Hakko in September 2024, 74 percent of supplement consumers indicated they would consider foods and beverages to support their immune health, validating the strategic pivot toward fortified functional nutrition.

Key Market Players

• Amway Corporation
• Herbalife Nutrition Ltd.
• Nestle S.A.
• Pfizer Inc.
• Bayer AG
• NOW Foods
• Nature's Bounty Co.
• GNC Holdings, Inc.
• Himalaya Drug Company
• Glanbia plc

Report Scope

In this report, the Global Immunity Boosting Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Immunity Boosting Products Market, By Type

• Supplement
• Beverages
• Food
• Others

Immunity Boosting Products Market, By Distribution Channel

• Supermarket/Hypermarkets
• Convenience Stores
• Medical Stores
• Online

Immunity Boosting Products Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunity Boosting Products Market.

Available Customizations:

Global Immunity Boosting Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunity Boosting Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Supplement, Beverages, Food, Others)
  • 5.2.2. By Distribution Channel (Supermarket/Hypermarkets, Convenience Stores, Medical Stores, Online)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Immunity Boosting Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Distribution Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Immunity Boosting Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Distribution Channel
  • 6.3.2. Canada Immunity Boosting Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Distribution Channel
  • 6.3.3. Mexico Immunity Boosting Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Distribution Channel

7. Europe Immunity Boosting Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Immunity Boosting Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Distribution Channel
  • 7.3.2. France Immunity Boosting Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Distribution Channel
  • 7.3.3. United Kingdom Immunity Boosting Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Distribution Channel
  • 7.3.4. Italy Immunity Boosting Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Distribution Channel
  • 7.3.5. Spain Immunity Boosting Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Distribution Channel

8. Asia Pacific Immunity Boosting Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Distribution Channel
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Immunity Boosting Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Distribution Channel
  • 8.3.2. India Immunity Boosting Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Distribution Channel
  • 8.3.3. Japan Immunity Boosting Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Distribution Channel
  • 8.3.4. South Korea Immunity Boosting Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Distribution Channel
  • 8.3.5. Australia Immunity Boosting Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Distribution Channel

9. Middle East & Africa Immunity Boosting Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Distribution Channel
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Immunity Boosting Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Distribution Channel
  • 9.3.2. UAE Immunity Boosting Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Distribution Channel
  • 9.3.3. South Africa Immunity Boosting Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Distribution Channel

10. South America Immunity Boosting Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Distribution Channel
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Immunity Boosting Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Distribution Channel
  • 10.3.2. Colombia Immunity Boosting Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Distribution Channel
  • 10.3.3. Argentina Immunity Boosting Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Immunity Boosting Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Amway Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Herbalife Nutrition Ltd.
• 15.3. Nestle S.A.
• 15.4. Pfizer Inc.
• 15.5. Bayer AG
• 15.6. NOW Foods
• 15.7. Nature's Bounty Co.
• 15.8. GNC Holdings, Inc.
• 15.9. Himalaya Drug Company
• 15.10. Glanbia plc

16. Strategic Recommendations

17. About Us & Disclaimer